Related Experiment Video
Updated: Dec 7, 2025

Mechanical Control of Relaxation Using Intact Cardiac Trabeculae
Published on: February 17, 2023
Trabeculated Myocardium in Hypertrophic Cardiomyopathy: Clinical Consequences
José David Casanova1, Josefa González Carrillo2,3,4, Jesús Martín Jiménez2,3
1Departamento de Ingeniería y Tecnología de Computadores, Universidad de Murcia, Espinardo, 30100 Murcia, Spain.
Insights
Trabeculated myocardium (TM) constitutes about 25% of the left ventricle in hypertrophic cardiomyopathy (HCM) patients. Increased TM proportion is linked to female sex, non-obstructive patterns, and reduced contractility, potentially identifying patients at risk for systolic heart failure.
Area of Science:
- Cardiology
- Cardiac Imaging
- Cardiovascular Disease
Background:
- Hypertrophic cardiomyopathy (HCM) is characterized by increased myocardial mass.
- The clinical significance of trabeculated myocardium (TM) in HCM remains unclear.
- Quantifying TM is essential for understanding its role in HCM pathophysiology.
Purpose of the Study:
- To measure left ventricular (LV) mass and the proportion of trabeculation in HCM patients.
- To investigate the clinical implications of trabeculated myocardium (TM) in hypertrophic cardiomyopathy (HCM).
- To analyze the association between TM proportion and clinical parameters in HCM.
Main Methods:
- Cardiac magnetic resonance (CMR) studies were performed on 211 HCM patients.
- Dedicated software automatically delineated LV trabecular and compacted myocardial borders.
- Trabeculated myocardium percentage (TM%) was calculated and analyzed against clinical factors.
Main Results:
- The mean TM% was 26.7% ± 6.4%, with significantly higher values in females (29.7% ± 7.2%) compared to males (25.6% ± 5.8%).
- Patients with LVEF < 50% exhibited higher TM% (30.2% ± 6.0%) compared to those with LVEF ≥ 50% (26.6% ± 6.4%).
- Female gender and neutral hypertrophy patterns were associated with increased TM%, while dynamic obstruction and maximal wall thickness were inversely associated.
Conclusions:
- Approximately 25% of the myocardium in HCM patients is trabeculated and measurable via automated software.
- Increased trabeculated myocardium proportion is observed in females, non-obstructive HCM, and patients with reduced contractility.
- Trabeculated myocardium may serve as a marker to identify HCM patients at risk for systolic heart failure.
Aims:
Hypertrophic cardiomyopathy (HCM) is often accompanied by increased trabeculated myocardium (TM)-which clinical relevance is unknown. We aim to measure the left ventricular (LV) mass and proportion of trabeculation in an HCM population and to analyze its clinical implication.
Methods And Results:
We evaluated 211 patients with HCM (mean age 47.8 ± 16.3 years, 73.0% males) with cardiac magnetic resonance (CMR) studies. LV trabecular and compacted mass were measured using dedicated software for automatic delineation of borders. Mean compacted myocardium (CM) was 160.0 ± 62.0 g and trabecular myocardium (TM) 55.5 ± 18.7 g. The percentage of trabeculated myocardium (TM%) was 26.7% ± 6.4%. Females had significantly increased TM% compared to males (29.7 ± 7.2 vs. 25.6 ± 5.8, p < 0.0001). Patients with LVEF < 50% had significantly higher values of TM% (30.2% ± 6.0% vs. 26.6% ± 6.4%, p = 0.02). Multivariable analysis showed that female gender and neutral pattern of hypertrophy were directly associated with TM%, while dynamic obstruction, maximal wall thickness and LVEF% were inversely associated with TM%. There was no association between TM% with arterial hypertension, physical activity, or symptoms. Atrial fibrillation and severity of hypertrophy were the only variables associated with cardiovascular death. Multivariable analysis failed to demonstrate any correlation between TM% and arrhythmias.
Conclusions:
Approximately 25% of myocardium appears non-compacted and can automatically be measured in HCM series. Proportion of non-compacted myocardium is increased in female, non-obstructives, and in those with lower contractility. The amount of trabeculation might help to identify HCM patients prone to systolic heart failure.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy V: Interprofessional Care
Mitral Regurgitation I: Introduction
Heart Failure II: Pathophysiology
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

